211 related articles for article (PubMed ID: 36560829)
1. Development of Fluorescence-Tagged SARS-CoV-2 Virus-like Particles by a Tri-Cistronic Vector Expression System for Investigating the Cellular Entry of SARS-CoV-2.
Chang YS; Chu LW; Chen ZY; Wu JS; Su WC; Yang CJ; Ping YH; Lin CW
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560829
[TBL] [Abstract][Full Text] [Related]
2. Virus-Like Particles of SARS-CoV-2 as Virus Surrogates: Morphology, Immunogenicity, and Internalization in Neuronal Cells.
Kumar CS; Singh B; Rizvi ZA; Parray HA; Verma JK; Ghosh S; Mukhopadhyay A; Awasthi A; Shrivastava T; Banerjee M
ACS Infect Dis; 2022 Oct; 8(10):2119-2132. PubMed ID: 36129193
[TBL] [Abstract][Full Text] [Related]
3. Dual-Fluorescence Labeling Pseudovirus for Real-Time Imaging of Single SARS-CoV-2 Entry in Respiratory Epithelial Cells.
Ma Y; Mao G; Wu G; Chen M; Qin F; Zheng L; Zhang XE
ACS Appl Mater Interfaces; 2021 Jun; 13(21):24477-24486. PubMed ID: 33961399
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.
Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T
mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537
[TBL] [Abstract][Full Text] [Related]
5. Optimized production and fluorescent labeling of SARS-CoV-2 virus-like particles.
Gourdelier M; Swain J; Arone C; Mouttou A; Bracquemond D; Merida P; Saffarian S; Lyonnais S; Favard C; Muriaux D
Sci Rep; 2022 Aug; 12(1):14651. PubMed ID: 36030323
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles.
Plescia CB; David EA; Patra D; Sengupta R; Amiar S; Su Y; Stahelin RV
J Biol Chem; 2021; 296():100103. PubMed ID: 33214224
[TBL] [Abstract][Full Text] [Related]
7. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
8. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
9. Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles.
Kumar B; Hawkins GM; Kicmal T; Qing E; Timm E; Gallagher T
Cells; 2021 Apr; 10(4):. PubMed ID: 33918600
[TBL] [Abstract][Full Text] [Related]
10. Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles.
Elfayres G; Paswan RR; Sika L; Girard MP; Khalfi S; Letanneur C; Milette K; Singh A; Kobinger G; Berthoux L
J Virol Methods; 2023 Dec; 322():114835. PubMed ID: 37871706
[TBL] [Abstract][Full Text] [Related]
11. Pseudotyping Improves the Yield of Functional SARS-CoV-2 Virus-like Particles (VLPs) as Tools for Vaccine and Therapeutic Development.
Zak AJ; Hoang T; Yee CM; Rizvi SM; Prabhu P; Wen F
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834067
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis.
Bayati A; Kumar R; Francis V; McPherson PS
J Biol Chem; 2021; 296():100306. PubMed ID: 33476648
[TBL] [Abstract][Full Text] [Related]
13. Development, production and characterization of SARS-CoV-2 virus-like particles (Coronaviridae:
Latyshev OE; Zaykova ON; Eliseeva OV; Savochkina TE; Chernoryzh YY; Syroeshkin AV; Petrov GV; Vorkunova GK; Larichev VF; Fediakina IT; Cherepushkin SA; Tsibezov VV; Yuzhakova KA; Kulikova NY; Lebedeva VV; Yakunin DY; Kozlova AA; Baranets MS; Yurlov KI; Lesnova EI; Grebennikova TV
Vopr Virusol; 2024 May; 69(2):175-186. PubMed ID: 38843023
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I
J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526
[TBL] [Abstract][Full Text] [Related]
15. The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles.
Boson B; Legros V; Zhou B; Siret E; Mathieu C; Cosset FL; Lavillette D; Denolly S
J Biol Chem; 2021; 296():100111. PubMed ID: 33229438
[TBL] [Abstract][Full Text] [Related]
16. Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment.
Jaron M; Lehky M; Zarà M; Zaydowicz CN; Lak A; Ballmann R; Heine PA; Wenzel EV; Schneider KT; Bertoglio F; Kempter S; Köster RW; Barbieri SS; van den Heuvel J; Hust M; Dübel S; Schubert M
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298643
[TBL] [Abstract][Full Text] [Related]
17. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
18. Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent.
Hsieh PK; Chang SC; Huang CC; Lee TT; Hsiao CW; Kou YH; Chen IY; Chang CK; Huang TH; Chang MF
J Virol; 2005 Nov; 79(22):13848-55. PubMed ID: 16254320
[TBL] [Abstract][Full Text] [Related]
19. Minimal system for assembly of SARS-CoV-2 virus like particles.
Swann H; Sharma A; Preece B; Peterson A; Eldredge C; Belnap DM; Vershinin M; Saffarian S
Sci Rep; 2020 Dec; 10(1):21877. PubMed ID: 33318562
[TBL] [Abstract][Full Text] [Related]
20. Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms.
Xu C; Wang A; Geng K; Honnen W; Wang X; Bruiners N; Singh S; Ferrara F; D'Angelo S; Bradbury ARM; Gennaro ML; Liu D; Pinter A; Chang TL
Viruses; 2021 May; 13(6):. PubMed ID: 34064066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
